Racial and ethnic differences in severity of coronary calcification among patients undergoing PCI: Results from a

Solomon W Bienstock1, Rajeev Samtani1, Ashton C Lai1

  • 1Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.

Insights

Hispanic patients undergoing percutaneous coronary intervention (PCI) had lower coronary artery calcium (CAC) scores than non-Hispanic patients, despite higher risk factors. This suggests current CAC scoring may underestimate risk in Hispanic populations.

Area of Science:

  • Cardiology
  • Public Health
  • Health Disparities

Background:

  • Racial disparities in coronary artery calcium (CAC) burden are known in population studies.
  • Associations between race/ethnicity and CAC in percutaneous coronary intervention (PCI) cohorts are not well understood.

Purpose of the Study:

  • To investigate the relationship between race/ethnicity and CAC burden in patients undergoing PCI.
  • To determine if existing CAC scoring accurately reflects risk across different racial/ethnic groups in a PCI population.

Main Methods:

  • Retrospective analysis of 1025 patients who underwent PCI between 2012 and 2020.
  • Patients categorized as non-Hispanic White (NHW), non-Hispanic Black (NHB), and Hispanic (H).
  • Negative binomial regression used to analyze associations between race/ethnicity and CAC scores, adjusting for clinical factors.

Main Results:

  • Median CAC scores varied significantly by race/ethnicity: NHW (760), NHB (500), and H (462).
  • Hispanic patients had a higher prevalence of diabetes, hypertension, and hyperlipidemia.
  • Adjusted analysis revealed significantly lower CAC in Hispanic patients compared to NHW (β = -324.1, p < 0.0001), while no significant difference was found for NHB patients.

Conclusions:

  • Hispanic patients undergoing PCI exhibit lower CAC burden despite a higher clinical risk profile.
  • Standardized CAC scoring may underestimate cardiovascular risk in the Hispanic population.
  • Developing race/ethnicity-specific CAC thresholds could improve risk stratification and clinical decision-making.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
161
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
46
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
70
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
75
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
498
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
100